Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy

Cancer remains an obstacle to be surmounted by humans. As an FDA-approved biocompatible drug excipient, d-α-tocopheryl polyethylene glycol succinate (TPGS) has been widely applied in drug delivery system (DDS). Along with in-depth analyses of TPGS-based DDS, increasingly attractive results have reve...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Songwei, Zou, Chenming, Zhang, Wei, Yin, Mingxing, Gao, Xueqin, Tang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241040/
https://www.ncbi.nlm.nih.gov/pubmed/29182031
http://dx.doi.org/10.1080/10717544.2017.1406561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241040/
https://www.ncbi.nlm.nih.gov/pubmed/29182031
http://dx.doi.org/10.1080/10717544.2017.1406561

Ejemplares similares